
Neion Bio uses genetic engineering to produce medicines in chicken eggs instead of massive industrial factories, dramatically lowering the cost of drug manufacturing.
Their platform turns eggs into efficient, self-contained drug factories capable of producing therapeutic proteins at a fraction of traditional costs. As drug shortages rise and manufacturing bottlenecks persist, Neion offers a faster, cheaper, and more resilient way to make life-saving medicines in America.